Wave Life Sciences Inc.
Organization details
- Legal name
- Wave Life Sciences Inc.
- Ownership
- Public
- Status
- Active
- Sector (GICS)
- Health Care
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Delaware
- Headquarters city
- Cambridge
- Headquarters state / province
- Massachusetts
- Headquarters country
- Singapore
- Fiscal year end
- December
- Ticker symbol
- WVE
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001631574
- Wikidata ID
- Q91396922
Board of directors
-
Adrian Rawcliffe · DirectorSince 2023
-
Aik Na Tan · DirectorSince 2023
-
Christian O. Henry · DirectorSince 2023
-
Gregory L. Verdine · DirectorSince 2023
-
Heidi L. Wagner · DirectorSince 2023
-
Ken Takanashi · DirectorSince 2023
-
Mark Corrigan · DirectorSince 2023
-
Paul Bolno · Director · President and CEOSince 2023
- Since 2023
- Since 2023
Chief executives
Director election results
Annual meeting of August 5, 2025. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
85.4%
-
95.4%
-
96.7%
-
98.9%
-
99.2%
-
99.6%
-
99.7%
-
99.8%
-
99.8%
Board connections
4 of this board's directors also sit on 27 other boards. 27 are in the same sector.
-
ARS Pharmaceuticals Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Acrivon Therapeutics Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Acumen Pharmaceuticals Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Artiva Biotherapeutics Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Bambusa Therapeutics Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Bicara Therapeutics Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Black Diamond Therapeutics Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Climb Bio Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Evommune Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Freenome Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Hemab Therapeutics Holdings Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Jade Biosciences Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Janux Therapeutics Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
LENZ Therapeutics Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Mineralys Therapeutics Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Nkarta Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Parabilis Medicines Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
PepGen Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Septerna Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Sionna Therapeutics Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Solid Biosciences Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
SpyGlass Pharma Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Tyra Biosciences Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Vor Biopharma Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Werewolf Therapeutics Inc. Same sectorvia Peter Kolchinsky and Rajeev M. Shah
-
Ginkgo Bioworks Holdings Inc. Same sectorvia Christian O. Henry
-
Invivyd Inc. Same sectorvia Paul Bolno
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $82,561,068
- 6 purchases by 2 insiders
- Sold, last 12 months
- $16,182,860
- 47 sales by 11 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Oct 5, 2026 | Mark Corrigan Director | Grant or award | +10,700 | — | — |
| Oct 5, 2026 | Christian O. Henry Director | Grant or award | +10,700 | — | — |
| Oct 5, 2026 | RA CAPITAL MANAGEMENT, L.P. Director, 10% owner | Grant or award | +10,700 | — | — |
| Oct 5, 2026 | Adrian Rawcliffe Director | Grant or award | +10,700 | — | — |
| Oct 5, 2026 | Ken Takanashi Director | Grant or award | +10,700 | — | — |
| Oct 5, 2026 | Aik Na Tan Director | Grant or award | +10,700 | — | — |
| Oct 5, 2026 | Gregory L. Verdine Director | Grant or award | +10,700 | — | — |
| Oct 5, 2026 | Heidi L. Wagner Director | Grant or award | +10,700 | — | — |
| Aug 12, 2026 | Adrian Rawcliffe Director | Open-market sale | −12,700 | $5.29 | $67,183 |
| Aug 11, 2026 | Ken Takanashi Director | Open-market sale | −3,864 | $6.01 | $23,223 |
| Aug 11, 2026 | Aik Na Tan Director | Open-market sale | −432 | $6.01 | $2,596 |
| Aug 11, 2026 | Heidi L. Wagner Director | Option exercise | +7,000 | $5.97 | $41,790 |
| Aug 11, 2026 | Heidi L. Wagner Director | Open-market sale | −7,000 | $6.01 | $42,070 |
| Mar 30, 2026 | RA CAPITAL MANAGEMENT, L.P. Director, 10% owner | Open-market purchase | +971,091 | $6.50 | $6,312,092 |
| Mar 27, 2026 | RA CAPITAL MANAGEMENT, L.P. Director, 10% owner | Open-market purchase | +2,495,623 | $6.43 | $16,046,856 |
Peers
Compare boardsOrganizations in the same sector, closest in location and size first.
Questions about Wave Life Sciences Inc.
Who is the CEO of Wave Life Sciences Inc.?
Paul Bolno is Wave Life Sciences Inc.'s President and CEO.
How many directors are on Wave Life Sciences Inc.'s board?
Wave Life Sciences Inc.'s board has 10 directors: Adrian Rawcliffe, Aik Na Tan, Christian O. Henry, Gregory L. Verdine, Heidi L. Wagner, Ken Takanashi, Mark Corrigan, Paul Bolno, Peter Kolchinsky and Rajeev M. Shah.
Are Wave Life Sciences Inc. insiders buying or selling shares?
Over the last 12 months, Wave Life Sciences Inc. insiders bought $82.6 million of shares in 6 purchases and sold $16.2 million of shares in 47 sales on the open market, as reported to the SEC on Forms 4 and 5.
Embed this board on your site
Paste this where the board should appear. It always shows the current directors and links back here.
<div data-bod-board="wave-life-sciences-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.